LIAISON VZV IgG HT, LIAISON Control VZV IgG HT— 510(k) K231214
Substantially EquivalentDiaSorin, Inc.
FDA 510(k) clearance K231214 for LIAISON VZV IgG HT, LIAISON Control VZV IgG HT, Substantially Equivalent on 2023-10-27. Applicant: DiaSorin, Inc.. Device class: 2.
Clearance details
- Applicant
- DiaSorin, Inc.
- Product code
- Code LFY
- Device class
- Class 2
- Regulation
- 21 CFR 866.3900
- Advisory panel
- Microbiology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Stillwater, MN, US
Recent devices under product code LFY
view allMore clearances from DiaSorin, Inc.
view all- K260770 — LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteX
- DEN250032 — LIAISON® XL MUREX Anti-HDV (318260); LIAISON® XL MUREX Control Anti-HDV (318261)
- K223403 — LIAISON Anti-HAV; LIAISON XS
- K213858 — LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus
- K213936 — LIAISON MeMed BV, LIAISON MeMed BV Control Set
Data sourced from openFDA. This site is unofficial and independent of the FDA.